P-selectin participates in cardiopulmonary bypass–induced inflammatory response in association with nitric oxide and peroxynitrite production  by Hayashi, Yoshitaka et al.
C ardiopulmonary bypass (CPB) is known to induce asystemic inflammatory response known as “post-
perfusion syndrome,” mainly caused by the blood con-
tact with artificial surfaces of the bypass circuit.1,2
Current evidence indicates strongly that neutrophils
play a pivotal role in the development of CPB-induced
inflammatory response.3 Generally, one of the neu-
trophil-mediated inflammatory responses is the interac-
tion of neutrophils with vascular endothelial cells via
adhesion molecules; the selectin family (E-, P-, and L-
selectin), the immunoglobulin superfamily (intercellu-
lar adhesion molecule-1: ICAM-1), and the integrins
(CD11/CD18 complex: Mac-1).4 Inhibition of the adhe-
Objectives: P-selectin participates in the development of inflammatory dis-
orders. Cardiopulmonary bypass is thought to induce inflammatory response
and increase nitric oxide production. To evaluate the role of P-selectin in
bypass-induced inflammatory response and its association with nitric oxide
production, we examined the effect of P-selectin monoclonal antibody in a
rat model of cardiopulmonary bypass. 
Methods: Twenty adult Sprague-Dawley rats undergoing cardiopulmonary
bypass for 60 minutes were divided into 2 groups. A 3-mg/kg dose of anti-
rat specific P-selectin monoclonal antibody (ARP2-4; Sumitomo
Pharmaceuticals, Osaka, Japan) was administered into the priming solution
before bypass in group P (n = 10) and a 3-mg/kg dose of PNB1.6 (non-
blocking monoclonal antibody) was added in group C for control (n = 10). 
Results: At the termination of bypass and 3 hours after the termination of
bypass, plasma levels of interleukins 6 and 8, nitrate/nitrite, the percentage
ratio of nitrotyrosine to tyrosine (an indicator of peroxynitrite formation),
and the respiratory index were significantly higher than before bypass in
both groups, and they were significantly lower in group P than in group C.
Plasma P-selectin level in group C and exhaled nitric oxide concentration in
both groups at termination of bypass were significantly lower than those
before bypass, and they were significantly higher 3 hours after termination
of bypass than before bypass in both groups. Plasma P-selectin level and
exhaled nitric oxide concentration in group P were significantly higher than
those in group C at the end of bypass, but they were significantly lower 3
hours after the termination of bypass.
Conclusions: These results demonstrate that P-selectin may participate in the
augmentation of bypass-induced inflammatory response in association with
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sion processes seems beneficial in attenuating the
inflammatory response, and prior studies have demon-
strated the effects of blocking various adhesion mole-
cules in animal inflammation models.5,6
P-selectin is an adhesion molecule that is constitu-
tively present in the Weibel-Palade bodies in endothe-
lial cells or α-granules in platelets, and it participates in
“rolling,” which is considered the first step of neu-
trophil migration into the postcapillary venules.7
Stimulation by histamine, thrombin, oxygen-derived
free radicals, or inflammatory cytokines, which are
CPB-induced chemotactic mediators, leads to the rapid
degranulation and translocation of P-selectin onto the
cell surface within a few minutes soon after the initia-
tion of inflammatory response.7 The subsequent up-
regulation of other adhesion molecules follows several
hours after “expression of P-selectin.”8 Thus, inhibiting
the earliest neutrophil-endothelial interactions, which
are mediated by P-selectin, appears suitable for clinical
application. The role of P-selectin in CPB-induced
inflammatory response has not been clarified, although
prior study in the fields of cardiovascular surgery has
demonstrated that blockade of P-selectin by species-
specific monoclonal antibody attenuates myocardial
ischemia-reperfusion injury.9
Nitric oxide (NO) is one of the most potent
vasodilators among the inflammation-mediated
vasoactive substances, and CPB has been reported to
enhance plasma NO production.10,11 Interleukin 6
(IL-6) and IL-8 are reported to be produced at the
early phase of CPB-induced inflammatory re-
sponse,12 and various chemotactic mediators subse-
quently induced are thought to produce inducible NO
synthase (iNOS),11 as well as to regulate some adhe-
sion molecules.13 The increase in NO production may
result in peroxynitrite formation by rapid reaction of
superoxide anion with NO, which is a potent oxi-
dant.14 Although NO and peroxynitrite have opposite
cytologic effects on the development of inflammation
and their roles remain unclear,15-18 NO itself is
thought to regulate P-selectin expression.19 To eluci-
date whether P-selectin participates in CPB-induced
inflammatory response in association with NO pro-
duction followed by reaction of peroxynitrite, we
examined the effect of a species-specific P-selectin
monoclonal antibody in a rat model of CPB.
Methods
Experimental protocol. Twenty adult male Sprague-
Dawley rats, weighing 400 to 450 g, underwent temporary
partial CPB with the use of a roller pump for 60 minutes.
The rats were randomly divided into 2 groups. In 1 group,
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a 3-mg/kg dose of “mouse anti-rat specific P-selectin
monoclonal antibody” (ARP2-4 blocking monoclonal anti-
body; Sumitomo Pharmaceuticals)9 was added into the
priming solution of the bypass circuit before CPB (group P,
n = 10). In the other group, a 3-mg/kg dose of PNB1.6
(Sumitomo Pharmaceuticals), which is a “nonblocking
monoclonal antibody,” was added in the same way for the
control group (group C, n = 10). All animals had received
humane care in compliance with the “Guide for the Care
and Use of Laboratory Animals” prepared by the Institute
of Laboratory Animal Resources and published by the
National Institutes of Health (NIH Publication No. 86-23,
revised 1985).
The rats were anesthetized by intraperitoneal administra-
tion of sodium pentobarbital (50 mg/kg) and placed in the
supine position. The lungs were ventilated with 100% oxygen
through an 18-gauge tracheotomy tube with a tidal volume of
10 mL/kg and a respiratory rate of 60 breaths/min. After
exposure of the cannulation sites, heparin (300 units/kg) was
injected intraperitoneally. Two 16-gauge catheters were
inserted via the right jugular vein into the right atrium and
directly into the left femoral vein. A 20-gauge catheter was
inserted directly into the left femoral artery.
The CPB circuits were composed of a roller pump (Perista
Bio-Minipump AC-2120; Atto Co, Ltd, Tokyo, Japan), a
membrane oxygenator (Senko Medical Co, Ltd, Osaka,
Japan), a venous reservoir, and a tubing line. None of the
materials in the CPB circuit were heparin coated. The bypass
circuit was primed with the following solution without blood
components: 12 mL of plasma expander containing hydroxy-
ethyl-amylum (Hespander; Kyorin Pharmaceutical, Tokyo,
Japan), 8 mL of lactated Ringer’s solution, 2 mL of 7% sodi-
um bicarbonate, 2 mL of mannitol, 100 units of heparin, and
1.5 mg of tobramycin. Perfusion flow rate was maintained at
100 mL · kg–1 · min–1, and perfusate temperature was main-
tained at 34°C with a heat exchanger. No blood components
were transfused throughout the experiment. Routinely, termi-
nation of CPB was aided by continuous administration of
dobutamine (3 µg · kg–1 · min–1). The remaining priming
solution was infused gradually after the termination of CPB.
A 1.5-mL sample of arterial blood and exhaled air was
obtained at the following 3 times: (1) before the initiation of
CPB, (2) at the termination of CPB, and (3) 3 hours after the
termination of CPB. Plasma levels of P-selectin, inflammato-
ry cytokines, and nitrate/nitrite, nitrotyrosine, and exhaled
NO concentration were measured to evaluate the effect of
ARP2-4. Respiratory index was obtained by measuring arte-
rial and alveolar PO2. 
Measurements 
Plasma levels of P-selectin. The blood sample was mixed
with citrate to a final concentration of 0.314%. Plasma was sep-
arated by centrifugation at 2000g for 15 minutes. The plasma
level of P-selectin was measured by enzyme-linked
immunosorbent assay with the use of anti-human P-selectin
polyclonal antibody (09361A; Pharmingen, San Diego, Calif)
and peroxidase-conjugated anti-rabbit immunoglobulin (P448;
DAKO, Glostrup, Denmark).20 Plasma P-selectin measured by
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this method is considered to be released both from platelets
destroyed by centrifugal force and from endothelial cells as a
result of CPB-induced endothelial activation.
Inflammatory cytokines. We measured plasma levels of IL-
6 and IL-8 as markers of CPB-induced inflammatory
response. The plasma IL-6 level was measured by enzyme-
linked immunosorbent assay with a commercially available
kit (Rat ELISA Kits; Biosource International, Camarillo,
Calif). The IL-8 level was measured by enzyme immunoas-
say with a commercially available kit (Rat IL-8 Kit; Panafarm
Laboratory, Tokyo, Japan).
Plasma nitrate/nitrite. The plasma fraction after centrifu-
gation was diluted 1:1 with nitrite- and nitrate-free distilled
water. Subsequently, 400 µL of diluted plasma was ultrafil-
tered at 2000g and its filtrates were analyzed by an automat-
ed procedure based on the Griess reaction.21
Nitrotyrosine (peroxynitrite) formation. Peroxynitrite has a
very short half-time in vivo and is usually measured in terms of
the formation of 3-nitro-L-tyrosine (nitrotyrosine), which is
generated by the nitration of tyrosine residues by peroxynitrite
itself22 and is relatively stable. Thus, we measured nitrotyro-
sine formation as an indicator of peroxynitrite production
using a high-pressure liquid chromatography method previous-
ly described.23 In brief, blood samples were centrifuged at
1200g for 15 minutes, and the filtrates were hydrolyzed for 24
hours. The supernatant fluid was analyzed by high-pressure
liquid chromatography with a C-18 reverse-phase column
(Jasco, Tokyo, Japan), and the peak concentrations were mea-
sured with an ultraviolet detector set at 274 nm (UV-970;
Jasco). The peak was identified on the basis of the retention
time of authentic 3-nitro-L-tyrosine (nitrotyrosine) or tyrosine.
Peroxynitrite formation was measured as the formation of
nitrotyrosine from tyrosine and expressed as the percentage
ratio of nitrotyrosine to tyrosine (%NTY, expressed as [nitroty-
rosine/tyrosine + nitrotyrosine] × 100%).23
Exhaled NO concentration. Mandatory ventilation consist-
ing of 5 mL of room air was performed 10 times with a 10-
mL syringe. The last 5 mL of exhaled air was subjected to
NO analysis. Three successive 1-mL samples of exhaled air
were measured with a chemiluminescence analyzer (Sievers
model 270B; Sievers Instruments, Boulder, Colo) sensitive to
NO at concentrations of 5 to 5 × 105 ppb within 30 minutes
after the collection of exhaled air. The average value from the
3 successive samples was used for analysis.24
Respiratory index. Respiratory index is an index of oxy-
genation function, and its increase reflects the presence of
pulmonary shunting in a variety of conditions including
atelectasis, pulmonary contusion, and pulmonary throm-
boembolism. Respiratory index was calculated by arterial
blood gas assay as follows: Respiratory index = (Alveolar –
arterial oxygen tension gradient)/Arterial oxygen tension. 
Histologic analysis. All rats were killed 3 hours after the
termination of CPB. Lung specimens were frozen and pre-
pared for immunohistologic examination.
ARP2-4 (Sumitomo Pharmaceuticals; dilution 1/250 in
phosphate-buffered saline solution) and peroxidase-conjugat-
ed goat anti-mouse immunoglobulin G (Sigma Chemical
Company, St Louis, Mo; dilution 1/10,000 in phosphate-
buffered saline solution) were used to evaluate the expression
of lung vascular P-selectin.25 Naphthol AS-D chloroacetate
esterase was used to evaluate neutrophil adhesion to lung
endothelial cells. Accumulated neutrophils and alveoli were
counted under a microscope at 100× magnification in 10
fields in all 10 serial sections. The results were corrected by
number of alveoli.
Statistical analysis. All data are expressed as mean ± stan-
dard deviation. Comparisons between groups were analyzed
by 2-way repeated-measures analysis of variance and the
unpaired Student t test. The Spearman rank correlation test
was used for analysis between exhaled NO concentration and
respiratory index. All analyses were performed with the
StatView version 5.0 statistical package (Abacus Concepts,
Inc, Berkeley, Calif).
Results
Plasma level of P-selectin. The 2 groups showed
similar levels of plasma P-selectin before the start of
CPB. Plasma P-selectin level at the termination of CPB
was significantly lower than that before CPB in group
C, and it was significantly higher in group P than in
group C. Three hours after the termination of CPB, the
level was significantly higher than before CPB in both
groups, but the level was significantly lower in group P
than in group C (Table I).
Inflammatory cytokines. In both groups, plasma
levels of IL-6 were below the minimum detectable
level before the initiation of CPB. Plasma IL-6 was
detected after the termination of CPB, and it was sig-
nificantly higher 3 hours after the termination of CPB
than at the termination of CPB. Plasma IL-6 levels in
group P were significantly lower than those in group C
both at the termination and 3 hours after the termina-
tion of CPB (Table I).
Plasma IL-8 levels before CPB were not significant-
ly different between the 2 groups, and the levels after
the termination of CPB were similar to the pattern of
IL-6. Both at the termination and 3 hours after the ter-
mination of CPB, plasma IL-8 levels in group P were
significantly lower than those in group C (Table I).
Plasma nitrate/nitrite. The plasma level of
nitrate/nitrite before CPB was not significantly differ-
ent between the groups. In both groups, the NO levels
after the termination of CPB were significantly higher
than those before CPB, and they were significantly
higher 3 hours after the termination of CPB than imme-
diately after the termination of CPB. The NO level in
group P was significantly lower than that in group C 3
hours after the termination of CPB, although there was
no significant difference immediately after the termina-
tion of CPB (Table I).
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Nitrotyrosine (peroxynitrite) formation.  Nitro-
tyrosine was not detected in the supernatant fluid
obtained before CPB in either group. In both groups, it
was detected after the termination of CPB, and the
%NTY 3 hours after the termination of CPB was sig-
nificantly higher than that at the termination of CPB.
The %NTY in group P was significantly lower than that
in group C at the termination of CPB, and the differ-
ence between the 2 groups remained at about the same
level of significance 3 hours after the termination of
CPB (Table I).
Exhaled NO concentration. The 2 groups had sim-
ilar concentrations of exhaled NO before CPB.
Exhaled NO concentration at the termination of CPB
was significantly lower than that before CPB in both
groups, but it was significantly higher 3 hours after
CPB than before CPB. At the termination of CPB, the
level in group P was significantly higher than that in
group C; however, 3 hours after the termination of
CPB, the level in group P was significantly lower than
that in group C (Table I).
Respiratory index. Respiratory indexes were not
significantly different before CPB between the 2
groups. Both groups showed significantly higher respi-
ratory indexes at the termination of CPB, and respira-
tory index 3 hours after the termination of CPB was
higher than that at the termination of CPB. In group P,
the respiratory indexes were significantly lower than
those in group C both at the termination of CPB and 3
hours after the termination of CPB (Table I).
There was a negative correlation between exhaled
NO and respiratory index at the termination of CPB
(group P: r = –0.781, P = .0056; group C: r = –0.813,
P = .0027) (Fig 1, A). However, there was no signifi-
cant correlation 3 hours after the termination of CPB
(group P: r = 0.570, P = .0825; group C: r = 0.522,
P = .1254) (Fig 1, B).
Histologic analysis. Histologic findings showed that
P-selectin expression and neutrophil accumulation in
the lung tissue were markedly inhibited in group P
compared with group C (Fig 2). The number of accu-
mulated neutrophils in group P (0.8 ± 0.3/alveoli) was
Table I.  Changes in plasma P-selectin, inflammatory cytokines (IL-6 and IL-8), nitrate/nitrite, %NTY, exhaled NO
concentration, and respiratory index
Pre-CPB CPB off Three hours after CPB
P-selectin (ng/mL)
Group C 187 ± 32.6 154 ± 27.1 305 ± 42.8
Group P 185 ± 28.1 179 ± 23.9 216 ± 32.9
P value .9 .04 <.0001
IL-6 (pg/mL)
Group C Under detectable 80 ± 15.6 307 ± 78.7
Group P Under detectable 56 ± 11.8 165 ± 42.2
P value .001 <.0001
IL-8 (ng/mL)
Group C 0.56 ± 0.14 4.61 ± 0.88 16.99 ± 2.79
Group P 0.58 ± 0.12 2.49 ± 0.68 8.07 ± 1.97
P value .8 <.0001 <.0001
Nitrate and nitrite (µmol/L)
Group C 24 ± 4.3 33 ± 4.7 53 ± 5.4
Group P 26 ± 4.1 31 ± 4.3 39 ± 3.9
P value .3 .2223 .0001
%NTY (%)
Group C Under detectable 0.55 ± 0.09 1.41 ± 0.27
Group P Under detectable 0.37 ± 0.06 0.88 ± 0.14
P value <.0001 <.0001
Exhaled NO concentration (ppb)
Group C 9.4 ± 1.07 6.8 ± 0.82 15.0 ± 2.24
Group P 9.4 ± 1.46 8.4 ± 1.09 11.6 ± 1.14
P value .97 .002 .0005
Respiratory index
Group C 0.30 ± 0.12 0.91 ± 0.19 1.54 ± 0.21
Group P 0.32 ± 0.11 0.61 ± 0.13 0.94 ± 0.17
P value .51 .0006 <.0001
CPB, Cardiopulmonary bypass; Pre-CPB, before the initiation of CPB; CPB off, at the termination of CPB; three hours after CPB, 3 hours after the termination of
CPB; IL, interleukin; %NTY, percentage ratio of nitrotyrosine to tyrosine; NO, nitric oxide. 
562 Hayashi et al The Journal of Thoracic and
Cardiovascular Surgery
September 2000
significantly smaller than that in group C (4.5 ±
0.4/alveoli, P < .01).
Discussion
Plasma P-selectin was characterized by Dunlop and
associates26 and has been reported to increase in septic
conditions as a result of endothelial activation and
damage.20 No experimental study demonstrating the
change in plasma P-selectin in an animal CPB model
has been reported; thus, this is the first experimental
study examining the change in plasma P-selectin asso-
ciated with CPB-induced inflammatory response in a
species other than Homo sapiens. Our present results in
the rat CPB model indicate that P-selectin plays a cru-
cial and interactive role in CPB-induced inflammatory
response. Blockade of P-selectin–mediated interaction
inhibited neutrophil accumulation in lung capillaries
and thereby attenuated the CPB-induced inflammatory
response. However, the mechanism by which CPB-
induced inflammatory response develops is complex.
These histologic findings alone may not account for the
effect on attenuating CPB-induced inflammatory
response.
P-selectin participates in the development of inflam-
matory response in various ways other than neu-
trophil–endothelial cell interaction; platelet-platelet
aggregation, and platelet-neutrophil adhesion.27
Recently, we28 demonstrated that ARP2-4 inhibits neu-
trophil–endothelial cell adhesion via activated
platelets, resulting in the attenuation of myocardial
reperfusion injury. Soon after the initiation of CPB,
blood contact with artificial surfaces rapidly induces
the up-regulation of P-selectin on the surface of both
platelets and endothelial cells.29,30 The decrease in
plasma level of P-selectin reflects the above platelet-
mediated interactions, and the increase reflects
endothelial activation. At the termination of CPB, the
change in plasma P-selectin appears mainly affected by
platelet-mediated interactions. Late after the termina-
tion of CPB, plasma P-selectin appears mainly affected
by the continuation of CPB-induced endothelial activa-
tion, as has been speculated. Our results are consistent
with the clinical study by Blume and associates,30
although no quantitative report about the origin of plas-
ma P-selectin has been presented, and further experi-
mental examination is needed.
Neutrophil–endothelial cell interaction is thought to
enhance the release of the chemotactic mediators.
Inflammatory cytokines, IL-6 and IL-8, are produced at
the early phase of CPB-induced inflammatory
response, and the production of these inflammatory
cytokines continues late after the termination of CPB,
which causes a CPB-induced inflammatory response.12
IL-8, in particular, is produced mainly from neu-
trophils. It activates the up-regulation of the integrin
onto the neutrophils and thereby plays a role in neu-
Fig 1.  A, Relationship between exhaled NO concentration and respiratory index at the termination of CPB (group
P: respiratory index = 1.382 – 0.091 ± 0.026 × exhaled NO, r2 = 0.609; group C: respiratory index = 2.228 – 0.192
± 0.049 × exhaled NO, r2 = 0.661). B, Relationship between exhaled NO concentration and respiratory index 3
hours after CPB (group P: respiratory index = –0.045 + 0.085 ± 0.043 × exhaled NO, r2 = 0.332; group C: respi-
ratory index = –0.825 + 0.048 ± 0.028 × exhaled NO, r2 = 0.273. CPB-off, At the termination of CPB; after 3 hrs,
3 hours after the termination of CPB; exhaled NO, exhaled NO concentration.
A B
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trophil transmigration.13 ARP2-4 may subsequently
attenuate further up-regulation of other adhesion mole-
cules and abnormal release of inflammatory cytokines,
which are considered as positive feedback processes of
the development of CPB-induced inflammatory
response.
The enhancement of plasma NO production during
and after CPB is considered dependent on the follow-
ing 2 pathways. After the initiation of CPB, mechanical
stimulation of vascular wall by CPB-induced blood
flow and hemodilution by CPB priming volume acti-
vate endothelial constitutive NOS.10 Several hours after
CPB, excessive NO is produced by the induction of
iNOS from activated blood components and inflamma-
tory cytokines.11 After the termination of CPB, ARP2-
4 reduced significantly the enhanced release of inflam-
matory cytokines such as IL-6 and IL-8. Although these
cytokines themselves have no iNOS-inducing activity,
the development of inflammation induces subsequent
iNOS expression several hours after CPB.11
Furthermore, tumor necrosis factor α and IL-1β, which
induce iNOS production, are released late after the ter-
mination of CPB when inflammation is severe.31 In this
short-term CPB model, ARP2-4 did not attenuate the
increase in NO at the termination of CPB. The reason
for this lack of effect may be partially that the increase
in NO at the termination of CPB mainly results from
endothelial-constitutive NOS activation induced by
CPB initiation itself.10
On the other hand, %NTY was significantly reduced
both at the termination of CPB and 3 hours after the ter-
mination of CPB, whereas plasma NO levels at the ter-
mination of CPB did not differ significantly between
the groups. Peroxynitrite production is defined by the
Fig 2.  Representative histologic findings of lung tissues after CPB. P-selectin expression and neutrophil accumu-
lation in ARP2-4–treated lung tissue were less than in non–ARP2-4 (PNB1.6)–treated lung tissue. A, P-selectin
expression in non–ARP2-4–treated lung tissue (group C). B, P-selectin expression was less in ARP2-4–treated lung
tissue (group P). C, Neutrophil accumulation in non–ARP2-4–treated lung tissue (group C). D, Neutrophil accu-
mulation was less in ARP2-4–treated lung tissue (group P).
A B
C D
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amounts of NO and superoxide anion.23,24 One of the
possible reasons is that ARP2-4 probably reduced
superoxide production as a result of attenuating P-
selectin–mediated inflammatory interactions, as well
as the release of inflammatory cytokines.
Generally, exhaled NO production is attributed to
neural NOS of lung epithelial cells in the pre-inflam-
matory state.32 As inflammation develops, iNOS
expression is induced and activated macrophages pro-
duce a great deal of exhaled NO.33 Thus, exhaled NO
is considered an indicator of lung injury in respiratory
diseases and septic conditions.34,35 However, the
change in exhaled NO after CPB remains unclear, and
its association with CPB-induced inflammatory
response has not been clarified.36 The present study
first suggested the association between the change in
exhaled NO and CPB-induced inflammatory response
in an experimental CPB model even though the
detailed mechanism, such as the roles of NOSs in
exhaled NO production, was not well characterized.
As one of the means of attenuating neutrophil-mediat-
ed interaction, leukocyte-depleted extracorporeal perfu-
sion, which Johnson and coworkers3 demonstrated in a
dog CPB model, seems beneficial in attenuating CPB-
induced inflammatory response. However, the technique
cannot be easily applied clinically, because continuous
use of the removal filter may reduce perfusion flow rate
and impair its ability to remove leukocytes. Moreover,
complete depletion of leukocytes appears to increase the
risk of infection. Our experimental results suggest that
blockade of P-selectin with species-specific monoclonal
antibody may be useful in attenuating neutrophil-mediat-
ed CPB-induced inflammatory response in view of suit-
able clinical application.
In summary, although the present study does not
completely simulate the clinical situation because the
pulmonary circulation is preserved in this rat CPB
model, it is the first to demonstrate the beneficial effect
of species-specific P-selectin monoclonal antibody on
CPB-induced inflammatory response. P-selectin,
which has been already shown to attenuate myocardial
ischemia-reperfusion injury, may help to augment
CPB-induced inflammatory response in association
with NO and peroxynitrite production. Thus, its mono-
clonal antibody against P-selectin seems to be a
promising treatment for CPB-induced inflammatory
response, although additional studies in the clinical set-
ting are needed.
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